516 related articles for article (PubMed ID: 20514634)
1. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
[TBL] [Abstract][Full Text] [Related]
2. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
[TBL] [Abstract][Full Text] [Related]
5. [Arrhythmogenic right ventricular dysplasia as a cause of "sudden cardiac death" with survival].
Brueck M; Theis RH; Krell W; Kramer W
Dtsch Med Wochenschr; 2003 Feb; 128(7):317-20. PubMed ID: 12584657
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
7. [Interventional treatment in hypertrophic cardiomyopathy].
Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
9. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
10. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
11. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
Chauhan VS; Selvaraj RJ
Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
[TBL] [Abstract][Full Text] [Related]
12. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
Wedekind H; Möller K
Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
[TBL] [Abstract][Full Text] [Related]
13. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
14. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
[TBL] [Abstract][Full Text] [Related]
16. [Risk stratification in atrial and ventricular arrhythmias].
Fauchier L; Robin I; de Labriolle A; Poret P; Giraudeau C; Cosnay P; Babuty D
Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):127-34. PubMed ID: 16792027
[TBL] [Abstract][Full Text] [Related]
17. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
[TBL] [Abstract][Full Text] [Related]
18. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive sudden death risk stratification.
Pedretti RF; Sarzi Braga S
Ital Heart J; 2005 Mar; 6(3):180-9. PubMed ID: 15875507
[TBL] [Abstract][Full Text] [Related]
20. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
Ansalone G; Ricci R; Cacciatore G; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
